| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |